Lexicon Pharmaceuticals Inc (LXRX)
1.72
-0.02
(-1.15%)
USD |
NASDAQ |
May 06, 09:57
Lexicon Pharmaceuticals Revenue (Quarterly): 1.13M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.13M |
| December 31, 2023 | 0.702M |
| September 30, 2023 | 0.162M |
| June 30, 2023 | 0.317M |
| March 31, 2023 | 0.024M |
| December 31, 2022 | 0.028M |
| September 30, 2022 | 0.039M |
| June 30, 2022 | 0.035M |
| March 31, 2022 | 0.037M |
| December 31, 2021 | 0.014M |
| September 30, 2021 | 0.023M |
| June 30, 2021 | 0.234M |
| March 31, 2021 | 0.027M |
| December 31, 2020 | 0.199M |
| September 30, 2020 | 6.634M |
| June 30, 2020 | 9.163M |
| March 31, 2020 | 7.999M |
| December 31, 2019 | 8.727M |
| September 30, 2019 | 294.45M |
| June 30, 2019 | 9.682M |
| March 31, 2019 | 9.216M |
| December 31, 2018 | 17.07M |
| September 30, 2018 | 6.966M |
| June 30, 2018 | 13.80M |
| March 31, 2018 | 25.37M |
| Date | Value |
|---|---|
| December 31, 2017 | 34.40M |
| September 30, 2017 | 26.94M |
| June 30, 2017 | 12.05M |
| March 31, 2017 | 18.29M |
| December 31, 2016 | 18.96M |
| September 30, 2016 | 27.72M |
| June 30, 2016 | 20.09M |
| March 31, 2016 | 12.49M |
| December 31, 2015 | 127.28M |
| September 30, 2015 | 0.566M |
| June 30, 2015 | 0.376M |
| March 31, 2015 | 1.792M |
| December 31, 2014 | 21.48M |
| September 30, 2014 | 0.419M |
| June 30, 2014 | 0.676M |
| March 31, 2014 | 0.277M |
| December 31, 2013 | 1.41M |
| September 30, 2013 | 0.238M |
| June 30, 2013 | 0.214M |
| March 31, 2013 | 0.36M |
| December 31, 2012 | 0.218M |
| September 30, 2012 | 0.372M |
| June 30, 2012 | 0.199M |
| March 31, 2012 | 0.30M |
| December 31, 2011 | 0.343M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.014M
Minimum
Dec 2021
294.45M
Maximum
Sep 2019
16.98M
Average
0.2165M
Median
Revenue (Quarterly) Benchmarks
| Windtree Therapeutics Inc | -- |
| AIM ImmunoTech Inc | 0.065M |
| Perspective Therapeutics Inc | -5.239M |
| Protalix BioTherapeutics Inc | 10.49M |
| Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.40M |
| Total Expenses (Quarterly) | 46.46M |
| EPS Diluted (Quarterly) | -0.20 |
| Enterprise Value | 172.75M |
| Gross Profit Margin (Quarterly) | 97.26% |
| Profit Margin (Quarterly) | -4.28K% |
| Earnings Yield | -48.26% |
| Normalized Earnings Yield | -48.26 |